Getting started with DCT in 2022
Castor advisor Craig Lipset, suggests that you consider DCT technology as three separate tiers. Learn more about these tiers and get started with DCT in 2022 with these pro tips.
It’s a Matter of Choice: Hybrid eConsent for On-Site or Remote Patient Enrollment
Thought leaders from Castor and Lightship discuss opportunities that will help researchers develop a more successful overall strategy for their patient enrollment.
Download this eBook to gain a comprehensive overview of eConsent, how it satisfies global regulatory requirements and key considerations for ethics board approval.
3 Ways eConsent Tackles the Challenges of Modern Clinical Trials
Although eConsent struggled to gain momentum and wider acceptance pre-pandemic, it’s now a major part of clinical research. In this article, learn three ways eConsent addresses the requirements for valid informed consent.
Trialbee and Castor Partner to Democratize Access and Simplify Enrollment to Clinical Trials Globally
Trialbee, the leading enrollment performance company, and Castor, a leading provider of decentralized and hybrid clinical trial solutions, today announced a strategic partnership to accelerate patient enrollment, optimize patient engagement, and reduce site burden for clinical trials globally.
The evolution of eConsent
Since it was first instituted in the 1960s, written consent to participate in research studies has undergone very little change other than tightening regulations and increased participant education of their rights.
What Is eConsent in Clinical Trials?
eConsent accelerates enrollment, increases retention, and reduces site burden. Find out why it’s the way of the future for clinical trials here.
Castor Leads Next-Gen Clinical Trials that Support Digital Therapeutics
Castor’s new eConsent platform will improve remote patient recruitment and enrollment as well as access to diverse populations by decentralizing clinical trials.
Three Ways Remote eConsent Improves Trial Efficiency
eConsent accelerates enrollment, increases retention, and reduces site burden. Learn why it’s the way of the future for clinical trials.
eConsent Readiness in 12 Countries
eConsent is imperative for continuing research during the COVID-19 pandemic and beyond, but regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 12 countries on the use of eSignature and eConsent in clinical trials.